Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment

Active, not recruiting

• Conditions: Fertility Preservation; Breast Cancer
• Interventions: Behavioral: web-based questionnaire

• Registration Number: NCT03817814
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

This study will help the researchers learn more about factors that affect the decisions about fertility preservation and family building made by young women with breast cancer.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2019-01-18
• Study First Submitted: 2019-01-21
• Study First Submitted QC: 2019-01-23
• Study First Posted: 2019-01-28
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-08
• Last Update Posted: 2024-02-09
• Primary Completion: 2025-01
• Study Completion: 2025-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 209

Inclusion Criteria

• Breast cancer, Stage 0-III
• Female
• 18-45 years of age at time of diagnosis
• Patients that completed their primary breast cancer treatment (surgery, chemotherapy, radiation therapy). Patients can still be on endocrine therapy, trastuzumab and/or pertuzumab therapy.
• Received education and counseling by MSK Fertility Nurse Specialist before beginning cancer treatment from 2009 through 2018

Read More

Exclusion Criteria

• Unable to read English

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Women with Breast Cancer	web-based questionnaire	This is a cross-sectional survey of young women with breast cancer (YWBC) who received a consultation with an MSK Fertility Nurse Specialist before starting cancer treatment.

Primary Outcome Measures

Name	Time	Method
Patient-reported outcome questionnaire - Fertility Preservation Questionnaire	1 year	Number of patients reporting that fertility tools were recommended to them following their breast cancer diagnosis

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States